AAAAAA
Results: 26-33/33
Authors:
Meluch, AA
Hainsworth, JD
Gray, JR
Thomas, M
Whitworth, PL
Davis, JL
Greco, FA
Citation: Aa. Meluch et al., Preoperative combined modality therapy with paclitaxel, carboplatin, prolonged infusion 5-fluorouracil, and radiation therapy in localized esophagealcancer: Preliminary results of a Minnie Pearl Cancer Research Network Phase II Trial, CA J SCI AM, 5(2), 1999, pp. 84-91
Authors:
Greco, FA
Hainsworth, JD
Citation: Fa. Greco et Jd. Hainsworth, Paclitaxel-based therapy in non-small-cell lung cancer: Improved third generation chemotherapy, ANN ONCOL, 10, 1999, pp. 63-67
Authors:
Hainsworth, JD
Burris, HA
Greco, FA
Citation: Jd. Hainsworth et al., Weekly administration of docetaxel (Taxotere): Summary of clinical data, SEMIN ONCOL, 26(3), 1999, pp. 19-24
Authors:
Hainsworth, JD
Greco, FA
Citation: Jd. Hainsworth et Fa. Greco, The current role and future prospects of paclitaxel in the treatment of small cell lung cancer, SEMIN ONCOL, 26(1), 1999, pp. 60-66
Authors:
Greco, FA
Hainsworth, JD
Citation: Fa. Greco et Jd. Hainsworth, The evolving role of paclitaxel for patients with carcinoma of unknown primary site, SEMIN ONCOL, 26(1), 1999, pp. 129-133
Authors:
Hainsworth, JD
Citation: Jd. Hainsworth, Extended-schedule oral etoposide in selected neoplasms and overview of administration and scheduling issues, DRUGS, 58, 1999, pp. 51-56
Authors:
Hainsworth, JD
Burris, HA
Erland, JB
Morrissey, LH
Meluch, AA
Kalman, LA
Hon, JK
Scullin, DC
Smith, SW
Greco, FA
Citation: Jd. Hainsworth et al., Phase I/II trial of paclitaxel by 1-hour infusion, carboplatin, and gemcitabine in the treatment of patients with advanced nonsmall cell lung carcinoma, CANCER, 85(6), 1999, pp. 1269-1276
Authors:
Hainsworth, JD
Burris, HA
Morrissey, LH
Greco, FA
Citation: Jd. Hainsworth et al., Phase I trial of paclitaxel, carboplatin, and topotecan with or without filgrastim (granulocyte-colony stimulating factor) in the treatment of patients with advanced, refractory cancer, CANCER, 85(5), 1999, pp. 1179-1185